[go: up one dir, main page]

RU2004110616A - Ингибитор матриксных металлопротеиназ - Google Patents

Ингибитор матриксных металлопротеиназ Download PDF

Info

Publication number
RU2004110616A
RU2004110616A RU2004110616/15A RU2004110616A RU2004110616A RU 2004110616 A RU2004110616 A RU 2004110616A RU 2004110616/15 A RU2004110616/15 A RU 2004110616/15A RU 2004110616 A RU2004110616 A RU 2004110616A RU 2004110616 A RU2004110616 A RU 2004110616A
Authority
RU
Russia
Prior art keywords
inhibitor
extract
matrix metalloproteinases
matrix metalloproteinase
ganoderma
Prior art date
Application number
RU2004110616/15A
Other languages
English (en)
Other versions
RU2283125C2 (ru
Inventor
Коджи ХАТТОРИ (JP)
Коджи ХАТТОРИ
Хироши МИЗУТАНИ (JP)
Хироши МИЗУТАНИ
Казухиса ОСУМИ (JP)
Казухиса ОСУМИ
Original Assignee
Ноногава Шоджи Лтд. (Jp)
Ноногава Шоджи Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ноногава Шоджи Лтд. (Jp), Ноногава Шоджи Лтд. filed Critical Ноногава Шоджи Лтд. (Jp)
Publication of RU2004110616A publication Critical patent/RU2004110616A/ru
Application granted granted Critical
Publication of RU2283125C2 publication Critical patent/RU2283125C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)

Claims (6)

1. Ингибитор матриксных металлопротеиназ, содержащий экстракт гриба Ganoderma.
2. Ингибитор матриксных металлопротеиназ, содержащий экстракт гриба Ganoderma atrum.
3. Ингибитор матриксных металлопротеиназ по любому из пп.1-2, отличающийся тем, что экстрагирующим растворителем является один или более растворителей, выбираемых из группы, состоящей из воды, низших спиртов и жидких многоатомных спиртов.
4. Лекарственные препараты, супрессоры метастазирования, содержащие ингибитор матриксных металлопротеиназ, который включает экстракт гриба Ganoderma atrum, и применяемые для подавления метастазирования.
5. Косметические средства, содержащие ингибитор матриксных металлопротеиназ, который включает экстракт гриба Ganoderma atrum, и применяемые как антиметастатические или подавляющие метастазирование средства.
6. Пищевые продукты, содержащие ингибитор матриксных металлопротеиназ, который включает экстракт гриба Ganoderma atrum, и применяемые как антиметастатические или подавляющие метастазирование средства.
RU2004110616/15A 2001-09-27 2002-09-27 Ингибитор матриксных металлопротеиназ RU2283125C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001297672 2001-09-27
JP2001-297672 2001-09-27

Publications (2)

Publication Number Publication Date
RU2004110616A true RU2004110616A (ru) 2005-04-20
RU2283125C2 RU2283125C2 (ru) 2006-09-10

Family

ID=19118704

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004110616/15A RU2283125C2 (ru) 2001-09-27 2002-09-27 Ингибитор матриксных металлопротеиназ

Country Status (11)

Country Link
US (1) US7618638B2 (ru)
EP (1) EP1449534B1 (ru)
KR (1) KR100644357B1 (ru)
CN (1) CN100518747C (ru)
AT (1) ATE506070T1 (ru)
CA (1) CA2460834C (ru)
DE (1) DE60239822D1 (ru)
ES (1) ES2365132T3 (ru)
RU (1) RU2283125C2 (ru)
TW (1) TWI318881B (ru)
WO (1) WO2003028749A1 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10166270B2 (en) 2004-04-23 2019-01-01 Zivo Bioscience, Inc. Composition and method for affecting cytokines and NF-κB
US7807622B2 (en) 2004-04-23 2010-10-05 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
CA2625818A1 (en) * 2005-04-20 2006-10-26 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
JP2007045713A (ja) * 2005-08-05 2007-02-22 Iskra Ind Co Ltd 霊芝胞子抽出物及び霊芝胞子製剤
CN102813672B (zh) * 2009-05-27 2013-11-06 西北大学 硫酸铝铵十二水在制备抗肿瘤基质金属蛋白酶抑制剂中的应用
US9486005B2 (en) 2010-02-22 2016-11-08 Smiti Vaid Gupta Agents and mechanisms for treating hypercholesterolemia
WO2014094918A1 (en) * 2012-12-21 2014-06-26 Aqua Bio Technology Asa Cosmetic compositions from fish hatching fluid
US10232028B2 (en) 2013-06-13 2019-03-19 Zivo Bioscience, Inc. Compounds and methods for affecting cytokines
EP3258948B1 (en) 2015-02-16 2023-12-06 Zivo Bioscience, Inc. Anti-inflammatory and immunomodulatory compositions comprising klebsormidium and uses thereof
EP3416501A4 (en) 2016-02-16 2019-11-20 Zivo Bioscience, Inc. NUTRITIONAL SUPPLEMENT FOR ANIMALS BY ADMINISTERING A FOOD SUPPLEMENT FROM ALGAE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62239953A (ja) 1986-04-11 1987-10-20 Yasahiro Morita 霊芝茶の製造法
JPH06345636A (ja) 1993-06-08 1994-12-20 Nonogawa Shoji Kk 化粧料
JPH0873369A (ja) 1994-09-01 1996-03-19 Fuairudo:Kk 健康茶
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
JP3611638B2 (ja) * 1995-08-02 2005-01-19 カネボウ株式会社 ヒトコラゲナーゼ活性阻害剤
JPH09235293A (ja) * 1996-02-29 1997-09-09 Kanebo Ltd 新規トリテルペン
CN1058190C (zh) * 1996-05-07 2000-11-08 陈帅民 一种记忆口服液
JPH11139947A (ja) 1997-11-11 1999-05-25 Sunstar Inc マトリックスメタロプロテアーゼ阻害剤含有口腔用組成物
JPH11180889A (ja) 1997-12-15 1999-07-06 Buhei Kono 霊芝からの抽出成分を含有する皮膚炎治療用薬液
CN1291511A (zh) 1999-10-10 2001-04-18 四川三优奇康产业股份有限公司 纯天然抗癌转移制剂

Also Published As

Publication number Publication date
WO2003028749A1 (fr) 2003-04-10
US20050037024A1 (en) 2005-02-17
CA2460834A1 (en) 2003-04-10
CN100518747C (zh) 2009-07-29
KR100644357B1 (ko) 2006-11-10
ATE506070T1 (de) 2011-05-15
EP1449534A4 (en) 2006-01-11
TWI318881B (ru) 2010-01-01
RU2283125C2 (ru) 2006-09-10
US7618638B2 (en) 2009-11-17
CN1561222A (zh) 2005-01-05
HK1072564A1 (zh) 2005-09-02
DE60239822D1 (de) 2011-06-01
CA2460834C (en) 2011-10-25
KR20040041629A (ko) 2004-05-17
EP1449534B1 (en) 2011-04-20
ES2365132T3 (es) 2011-09-22
EP1449534A1 (en) 2004-08-25

Similar Documents

Publication Publication Date Title
RU2004110616A (ru) Ингибитор матриксных металлопротеиназ
ATE274330T1 (de) Gleitschutz fur einen gehäusekopf medizinischer instrumente
ES2194997T3 (es) Procedimiento enzimatico para el desmucilaginado de aceites vegetales mediante fosfolipasa de aspergillus.
MD940085A (ru) Пиразолкарбоксанилидные фунгициды
RU95106996A (ru) Сульфонилалканоиламино-гидроксиэтиламино-сульфонамидные соединения, фармацевтические композиции и способы лечения и ингибирования ретровирусных протеаз
DE60112957D1 (de) Sulfamide als gamma-secretase-inhibitoren
AR027788A1 (es) Proceso de desinfectar una superficie dura con una composicion que comprende aceite de canela y/o un activo de este
MA23084A1 (fr) Compositions cosmetiques contenant des pigments traites en surface .
PE20020336A1 (es) Composicion farmaceutica que comprende un inhibidor de lipasa y un secuestrante de acidos biliares
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
ATE253351T1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
WO2002028829A3 (en) Peptide deformylase inhibitors
WO2001096606A3 (en) Identification of genes and compounds for treatment of cancer
WO1999016410A3 (en) Low residue solid antiperspirant
DK1438013T3 (da) Naturlig emulgator til kosmetik basiseret på olivenolie
ATE294567T1 (de) Flüssige reinigungsmittelzusammensetzung
DE69226878D1 (de) Extraktion von wasser aus öl
PL328916A1 (en) Compositions containing inhibitors of hiv protease, such as vx 478 and water-soluble vitamin e compound such as vitamin e-tpgs
EP1341535A4 (en) SKIN WHITENING AGENT CONTAINING HYDROXYTETRONIC ACID
MY126236A (en) Novel fungicidal compositions based on propamocarb and pyridylmethylbenzamide derivatives
DE69831737D1 (de) Neurotrypsin
ATE301933T1 (de) Akarizidpulver
SE9202881D0 (sv) Saett att avlaegsna parasiter
FI951078A0 (fi) Retrovirusinfektion inhibitio
AU9743598A (en) Cosmetic products